Table: Fuji Pharmaceutical -2017/18 group results

Fuji Pharma

09/11/2018 07:30

Nov 9 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Sep 30, 2018    Sep 30, 2017   Sep 30, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           37.91           35.39          36.82        18.75    
               (+7.1 pct)      (+3.4 pct)     (-2.9 pct)    (+4.4 pct) 
  Operating        4.39            4.31           4.54         2.57    
               (+1.8 pct)      (+20.9 pct)    (+3.3 pct)   (+13.1 pct) 
  Recurring        4.47            4.63           4.51         2.61    
               (-3.4 pct)      (+42.3 pct)    (+0.8 pct)   (+10.6 pct) 
  Net
  Net              3.37            3.30           3.40         1.89    
               (+2.2 pct)      (+55.8 pct)    (+0.7 pct)    (+8.2 pct) 
  EPS          112.68 yen      110.32 yen     113.51 yen    63.04 yen  
  Ann Div                       48.00 yen      29.00 yen               
  -Q2 Div       28.00 yen       23.00 yen      14.00 yen               
  -Q4 Div       14.00 yen       25.00 yen      15.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T